Undecanoic acid, zinc salt (2:1) | 14992-20-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Undecanoic acid, zinc salt (2:1)
• 英文别名: zinc;undecanoate
• CAS: 14992-20-2
• 化学式: C22H42O4Zn
• 分子量: 435.9
• InChiKey: OBOMINCSAYZPGH-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  4.53
• 重原子数：
  27
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  80.3
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• METHOD FOR PRODUCING ISOCYANATES
  申请人：Kloetzer Matthias

  公开号：US20090275775A1

  公开（公告）日：2009-11-05

  The invention relates to a multistage process for the continuous preparation of organic, distillable isocyanates, preferably diisocyanates, particularly preferably aliphatic or cycloaliphatic diisocyanates, by reaction of the corresponding organic amines with urea and alcohols to liberate ammonia and form low molecular weight monomeric urethanes and thermal dissociation of the latter, in which by-products formed are at least partly utilized.

  本发明涉及一种多级过程，用于连续制备有机可蒸馏异氰酸酯，优选双异氰酸酯，特别优选脂肪族或环脂肪族双异氰酸酯。该过程通过将相应的有机胺与尿素和醇反应以释放氨并形成低分子量单体脲和热解后，利用至少部分形成的副产物。
• Resin composition, method of its composition, and cured formulation
  申请人：NIPPON SHOKUBAI CO., LTD.

  公开号：EP1626065A1

  公开（公告）日：2006-02-15

  It is an object of the present invention to provide a resin composition which can form cured formulations having various excellent properties such as an insulating property, thermal shock resistance, moldability/formability and strength, and exhibit an excellent appearance inwhich transparency is enhanced, a resin composition whose cured thin film has excellent flame retardancy, good mechanical property and heat resistance, a dispersing element containing an inorganic microfine particle which can give a flame retardancy to a resin, to which the inorganic microfine particle is added, and can reduce a hygroscopic property to the extent possible, a method for producing the same and a cured formulation obtained by using the resin composition. The present invention relates to a resin composition comprising a compound having at least one of a glycidyl group and/or an epoxy group and an inorganic microfine particle, a resin composition comprising three components of a phenolic compound, a compound having at least one of a glycidyl group and/or an epoxy group and an inorganic microfine particle, a flame retardant resin composition comprising a polyhydric phenol and an inorganic microfine particle, and a dispersing element containing an inorganic microfine particle obtained by a hydrolysis condensation reaction of alkoxide and/or metal carboxylate in a dispersion medium.

  本发明的目的是提供一种树脂组合物，该树脂组合物可形成具有各种优异性能（如绝缘性、抗热震性、成型性/可成形性和强度）的固化配方，并表现出优异的外观（其中透明度得到提高）；一种树脂组合物，该树脂组合物的固化薄膜具有优异的阻燃性、本发明涉及一种树脂组合物，其固化薄膜具有优异的阻燃性、良好的机械性能和耐热性；一种含有无机微细颗粒的分散元素，该分散元素可使添加了无机微细颗粒的树脂具有阻燃性，并可尽可能降低吸湿性；一种生产方法；以及一种通过使用该树脂组合物获得的固化配方。本发明涉及一种树脂组合物，该树脂组合物由至少一个具有缩水甘油基和/或环氧基的化合物和无机微细颗粒组成；一种树脂组合物，该树脂组合物由酚类化合物、至少一个具有缩水甘油基和/或环氧基的化合物和无机微细颗粒三部分组成、一种阻燃树脂组合物，包括一种多羟基酚和一种无机微细颗粒，以及一种含有无机微细颗粒的分散元件，该无机微细颗粒是通过烷氧基和/或金属羧酸盐在分散介质中的水解缩合反应获得的。
• RESIN COMPOSITION AND MULTILAYER STRUCTURE USING SAME
  申请人：The Nippon Synthetic Chemical Industry Co., Ltd.

  公开号：EP3395892A1

  公开（公告）日：2018-10-31

  A resin composition includes: an ethylene-vinyl ester copolymer saponified product (A) ; and fatty acidmetal salts, wherein the fatty acid metal salts include at least two fatty acid metal salts selected from a fatty acid metal salt having 3 to 12 carbon atoms (B), a fatty acid metal salt having 13 to 20 carbon atoms (C), and a fatty acid metal salt having 21 to 29 carbon atoms (D), and wherein at least one of the fatty acid metal salts selected from the fatty acid metal salts (B), (C), and (D) includes a zinc salt. The resulting resin composition is capable of forming a multilayer structure that has suppressed occurrence of appearance failure and minimized color tone deterioration at the time of its melt molding.

  一种树脂组合物包括乙烯-乙烯酯共聚物皂化产品（A）；以及脂肪酸金属盐，其中脂肪酸金属盐包括至少两种选自具有 3 至 12 个碳原子的脂肪酸金属盐（B）、具有 13 至 20 个碳原子的脂肪酸金属盐（C）和具有 21 至 29 个碳原子的脂肪酸金属盐（D）的脂肪酸金属盐，并且其中至少一种选自脂肪酸金属盐（B）、（C）和（D）的脂肪酸金属盐包括锌盐。由此得到的树脂组合物能够形成多层结构，在熔融成型时能够抑制外观故障的发生，并将色调劣化降到最低。
• MULTILAYER STRUCTURE, RESIN COMPOSITION FOR ADHESIVE RESIN LAYERS, AND METHOD FOR PRODUCING MULTILAYER STRUCTURE
  申请人：The Nippon Synthetic Chemical Industry Co., Ltd.

  公开号：EP3492261A1

  公开（公告）日：2019-06-05

  A multilayer structure includes an adhesive resin layer provided between a thermoplastic resin layer and a gas barrier resin layer, wherein the adhesive resin layer is formed from a resin composition containing a polyolefin resin (A) containing at least one of a carboxyl group and an acid anhydride group, and a fatty acid zinc salt (B), wherein the fatty acid zinc salt (B) is present in the resin composition in a proportion of 40 to 250 ppm on a metal basis based on the amount of the adhesive resin layer. The multilayer structure has a higher level of transparency, because interface roughness in an interface between the gas barrier layer and the adhesive resin layer is significantly suppressed.

  一种多层结构包括设置在热塑性树脂层和气体阻隔树脂层之间的粘合剂树脂层，其中粘合剂树脂层由含有聚烯烃树脂（A）的树脂组合物形成，聚烯烃树脂（A）含有羧基和酸酐基中的至少一个基团和脂肪酸锌盐（B），其中脂肪酸锌盐（B）以粘合剂树脂层的用量为基准，在树脂组合物中的金属含量比例为 40 至 250 ppm。由于气体阻隔层和粘合剂树脂层之间的界面粗糙度显著降低，多层结构具有更高的透明度。
• Pharmaceutical formulations for the oral delivery of peptide drugs
  申请人：Cyprumed GmbH

  公开号：US10905744B2

  公开（公告）日：2021-02-02

  The present invention relates to improved pharmaceutical formulations, uses and methods for the oral delivery of peptide drugs with advantageously high bioavailability, safety and costeffectiveness. In particular, the invention provides a peptide drug having a molecular weight of equal to or less than 5 kDa for use as a medicament, wherein said peptide drug is to be administered orally in combination with a pharmaceutically acceptable copper salt/complex and/or a pharmaceutically acceptable zinc salt/complex and/or a pharmaceutically acceptable iron salt/complex, and with a pharmaceutically acceptable complexing agent. The invention also provides a pharmaceutical composition comprising: a peptide drug having a molecular weight of equal to or less than 5 kDa; a pharmaceutically acceptable copper salt/complex and/or a pharmaceutically acceptable zinc salt/complex and/or a pharmaceutically acceptable iron salt/complex; and a pharmaceutically acceptable complexing agent.

  本发明涉及肽类药物口服给药的改进药物制剂、用途和方法，具有生物利用度高、安全和成本效益高等优点。特别是，本发明提供了一种分子量等于或小于 5 kDa 的多肽药物，可用作药物，其中所述多肽药物将与药学上可接受的铜盐/络合物和/或药学上可接受的锌盐/络合物和/或药学上可接受的铁盐/络合物以及药学上可接受的络合剂一起口服给药。本发明还提供了一种药物组合物，其中包括：分子量等于或小于 5 kDa 的多肽药物；药学上可接受的铜盐/络合物和/或药学上可接受的锌盐/络合物和/或药学上可接受的铁盐/络合物；以及药学上可接受的络合剂。